Pneumonia in Children
9
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.4% vs benchmark
11%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (9)
AI-Guided Mechanical Ventilation in Children: A Randomized Controlled Trial
Bubble CPAP Team-Based Care Strategy Feasibility Trial
Using Artificial Intelligence To Improve Ventilator Settings For Intensive Care Patients
Effects of Balloon Blowing Therapy and Bubble PEP on Oxygen Saturation, Dyspnea, and Enjoyment in Pediatric Pneumonia
Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia
Opportunistic Pneumococcal Immunisation Trial in MALnutrition
Development of a Robust and Reliable Pulse Oximeter for Children With Pneumonia in Low-income Countries
Roles of Some Non-classic Biomarkers in Pediatric Pneumonia
Utility of Continuous Pulse Oximetry for Pediatric Patients With Stable Respiratory Illness